重症监护室患者保守与宽松氧合目标(ICONIC):一项随机临床试验
该多中心随机试验纳入预计机械通气至少24小时的ICU患者,1:1随机至低氧合目标(PaO2 55-80 mm Hg或SpO2 91-94%)或高氧合目标(PaO2 110-150 mm Hg或SpO2 96-100%),持续至ICU出院或随机后28天。因COVID-19疫情提前终止,计划1512例中实际纳入664例(低氧合组335例,高氧合组329例)。28天死亡率低氧合组129例(38.5%)、高氧合组114例(34.7%),风险比1.11(95%CI 0.9-1.4,P=0.30),至少一次严重不良事件分别为12例(3.6%)和17例(5.2%)。作者结论认为低氧合策略未降低28天死亡率。
要点
- 机械通气≥24小时的ICU患者,低氧合目标(PaO2 55-80 mm Hg或SpO2 91-94%)较高氧合目标(PaO2 110-150 mm Hg或SpO2 96-100%)未降低28天死亡率(38.5% vs 34.7%,RR 1.11,95%CI 0.9-1.4,P=0.30)。
- 实际达到的PaO2中位数低氧合组75 mm Hg(IQR 70-84)、高氧合组115 mm Hg(IQR 100-129),两组分离良好。
- 至少一次严重不良事件低氧合组12例(3.6%)、高氧合组17例(5.2%)。
- 研究因COVID-19疫情提前终止,计划1512例中仅纳入664例(低氧合组335例、高氧合组329例)。
适用人群与场景
- 机械通气ICU患者,预计机械通气持续时间至少24小时。
诊断标准与关键阈值
- 低氧合目标:PaO2 55-80 mm Hg,或脉搏血氧饱和度91-94%。
- 高氧合目标:PaO2 110-150 mm Hg,或脉搏血氧饱和度96-100%。
- 目标维持至ICU出院或随机后28天,以先到者为准。
处置流程与药物剂量
- 随机1:1分配至低氧合目标(PaO2 55-80 mm Hg或SpO2 91-94%)或高氧合目标(PaO2 110-150 mm Hg或SpO2 96-100%)。
研究设计与关键结果
- 多中心随机临床试验,2018年11月至2021年11月纳入664例机械通气ICU患者,低氧合组335例、高氧合组329例。
- 主要终点28天死亡率:低氧合组129例(38.5%)vs 高氧合组114例(34.7%),风险比1.11(95%CI 0.9-1.4,P=0.30)。
- 实际达到PaO2中位数:低氧合组75 mm Hg(IQR 70-84)vs 高氧合组115 mm Hg(IQR 100-129)。
- 至少一次严重不良事件:低氧合组12例(3.6%)vs 高氧合组17例(5.2%)。
- 研究因COVID-19疫情提前终止,计划纳入1512例,实际纳入664例。
证据类型、等级与局限
- 随机临床试验;试验注册于National Trial Register及International Clinical Trials Registry Platform(NTR7376)。
- 局限:研究因COVID-19疫情提前终止,计划1512例中仅纳入664例。
对床旁实践的改变
- 作者结论:在预计机械通气至少24小时的机械通气ICU患者中,采用低氧合策略较高氧合策略未降低28天死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Supplemental oxygen is widely administered to ICU patients, but appropriate oxygenation targets remain unclear. Objectives: This study aimed to determine whether a low-oxygenation strategy would lower 28-day mortality compared with a high-oxygenation strategy. Methods: This randomized multicenter trial included mechanically ventilated ICU patients with an expected ventilation duration of at least 24 hours. Patients were randomized 1:1 to a low-oxygenation (PaO2, 55-80 mm Hg; or oxygen saturation as measured by pulse oximetry, 91-94%) or high-oxygenation (PaO2, 110-150 mm Hg; or oxygen saturation as measured by pulse oximetry, 96-100%) target until ICU discharge or 28 days after randomization, whichever came first. The primary outcome was 28-day mortality. The study was stopped prematurely because of the COVID-19 pandemic when 664 of the planned 1,512 patients were included. Measurements and Main Results: Between November 2018 and November 2021, a total of 664 patients were included in the trial: 335 in the low-oxygenation group and 329 in the high-oxygenation group. The median achieved PaO2 was 75 mm Hg (interquartile range, 70-84) and 115 mm Hg (interquartile range, 100-129) in the low- and high-oxygenation groups, respectively. At Day 28, 129 (38.5%) and 114 (34.7%) patients had died in the low- and high-oxygenation groups, respectively (risk ratio, 1.11; 95% confidence interval, 0.9-1.4; P = 0.30). At least one serious adverse event was reported in 12 (3.6%) and 17 (5.2%) patients in the low- and high-oxygenation groups, respectively. Conclusions: Among mechanically ventilated ICU patients with an expected mechanical ventilation duration of at least 24 hours, using a low-oxygenation strategy did not result in a reduction of 28-day mortality compared with a high-oxygenation strategy. Clinical trial registered with the National Trial Register and the International Clinical Trials Registry Platform (NTR7376).
参考来源
- van der Wal LI, Grim CCA, Del Prado MR, et al. Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial. Am J Respir Crit Care Med. 2023. PMID: 37552556. doi:10.1164/rccm.202303-0560OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。